We have been receiving questions regarding our injectable products. For example, does our anesthetic contain graphene, graphene oxide, graphene hydroxide or the technology (not perhaps an ingredient) that would be termed lipid nanoparticles or hydrogel. We believe the real question is do our injectable products contain an ingredient, technology or a payload that is not needed for the function of the product itself. In an effort to find answers, we are pleased to announce our collaboration with The International Academy of Oral Medicine and Toxicology and DAMS INC. These partnerships mark a significant step forward in enhancing our capabilities to continue researching the safety of dental anesthetic.
The International Academy of Oral Medicine and Toxicology (IAOMT) is a global network of dentists, health professionals, and scientists. They are a non-profit organization and have been dedicated to their mission of protecting public health and the environment since they were founded in 1984. They accomplish their mission by funding, investigating and promoting non-invasive scientifically valid therapies, and educating medical and dental professionals, policy-makers, and the general public. The IAOMT has a federal tax exempt status as a non-profit organization under section 501(c)(3) of the Internal Revenue Code, with Public Charity Status 509(a)(2).
DAMS INC is a 501(c)(3) tax exempt non-profit that educates the public on the dental-health connection. DAMS provides science-based information on how dental materials and dental treatment methods may affect the patient's health. The hope is that, by providing objective information, patients will be able to make well informed decisions about their dental care.
DAMS may be contacted at 651-644-4572, dams@usfamily.net and www.amalgam.org.
We will continue to post information on this page as we receive it. If you would like to reach out to Dr. Lundstrom with questions, you can reach him via email at lundstrommanager@protonmail.com.
WHAT DENTAL ANESTHETIC HAS BEEN TESTED?
Articaine Hydrochloride 4% and epinephrine 1:200,000
Manufacturer: Pierrel
Brand Name: Orabloc
WHO HAS COMPLETED TESTING ON THE DENTAL ANESTHETIC?
Dr. Ana Maria Mihalcea
She completed testing using Dark Field Microscopy. Her preliminary results are posted below in our August 9, 2023 update.
Medicinal Genomics: Kevin McKernan
He completed testing using Genomic Sequencing. His results are posted below in our September 28, 2023 update.
University of Colorado Boulder: Jessica C. Hankins, Sr Professional Research Assistant, Raman Microspectroscopy and Geomicrobiology Lab Manager
She completed testing using Raman Microspectroscopy. Her results are posted below in our July 22, 2024 update.
ANESTHETIC TEST RESULTS
Date: July 22, 2024
Is there Graphene in dental anesthetic?
We asked the University of Colorado Boulder to test samples of dental anesthetic. We sent samples of Articaine Hydrochloride 4% and epinephrine 1:200,000, lot number (10) 230109 for testing. The testing was completed using Raman Microspectroscopy. At the conclusion of testing, Jessica C. Hankins, Sr Professional Research Assistant, Raman Microspectroscopy and Geomicrobiology Lab Manager reports "I can affirm the presence of graphene oxide particles in this anesthetic with high confidence."
You can view the full report here:
Date: September 28, 2023
Is there RNA or DNA in dental anesthetic?
We asked Kevin McKernan with Medicinal Genomics to test samples of dental anesthetic. The testing was completed on Articaine Hydrochloride 4% and epinephrine 1:200,000, lot number (10) 230109. At the conclusion of testing, he reports no detectable vaccine derived RNA or DNA is present in the anesthetic.
You can view the full report here:
Date: August 9, 2023
Preliminary testing results from Dr. Ana Maria Mihalcea
Dr. Ana Maria Mihalcea was first to respond to our request for testing the lot of dental anesthetic. She completed her testing on Articaine Hydrochloride 4% and epinephrine 1:200,00, lot number (10) 230109 using Dark Field Microscopy. Her preliminary results are partially available on her substack @anamihalceamdphd and you can also view the substack article below.
You can view the report here:
WHO HAVE WE CONTACTED ABOUT TESTING THE DENTAL ANESTHETIC?
We have reached out to many sources to inquire about getting testing completed either through them/their universities or asking them to provide us with contacts for a trusted testing site. Along with asking for testing to be completed, we have also provided some of the sources with samples of dental anesthetic for testing. Below you will see the efforts we have made in trying to pursue testing and some of the responses we have received.
Dr. Gossweiler, DDS, NMD, IAOMT Science Committee Member
August 9, 2023 we provided a sample of dental anesthetic for testing but haven't received confirmation that testing will be completed.
Jacob Erstling, PhD, Cornell Alum, Director of Internal Production at Eulicida Oncology, Inc
December 20, 2023 we provided a sample of dental anesthetic for testing. We also inquired about how someone could detect the presence of C'Dots or related nanotechnology and what testing methods could be used for this. No response has been received.
Ulrich Wiesner, Cornell University Spencer T. Olin Professor in the Department of Materials Science and Engineering
December 20, 2023 we provided a sample of dental anesthetic for testing. We also inquired about how someone could detect the presence of C'Dots or related nanotechnology and what testing methods could be used for this. No response has been received.
The University of Utah, Utah Nanofab
The University of Utah website states: Utah Nanofab has become a world leader in the fabrication of neural prosthetics, biomedical microfluidic systems and biosensor chips. Utah Nanofab has the specialized custom-built infrastructure, equipment, processes, and expertise necessary for researchers and companies to design, build, and package revolutionary micro and nanoscale devices.
Paulo Perez, The University of Utah, Utah Nanofab, University Surface Scientist
November 30, 2023 we provided a sample of dental anesthetic for testing. No response has been received.
Brian Van Devener, The University of Utah, Utah Nanofab Surface Analysis Lab Manager, University Surface Scientist
November 30, 2023 we provided a sample of dental anesthetic for testing.
December 19, 2023 received response stating "Upon reviewing your request, this looks like something that is beyond the scope of our normal capabilities."
Stew Peters
No response received
Truth for Health Foundation
June 27, 2023 receipt of information confirmed but no response on testing
Todd Callender, Attorney at Disabled Rights Advocates
No response received
Mike Adams "The Health Ranger", Lab Science Director of CWC (Consumer Wellness Center) Labs
No response received
Dr. Richard Fleming, PhD, MD, SD, Creator of The Fleming Method
July 27, 2023 responded with potential testing methods but did not complete testing
FLCCC (Front Line Covid-19 Critical Care Alliance)
July 29, 2023 responded stating "We are a small non-profit that may seem very large because of our outreach, but we just don't have the resources or the funds to help with this. Once the data is gathered and there is evidence to prove that this is truly an issue of concern, then we can explore this further to see if we can make a difference through educating patients, consumers, and the anesthesia community on the risks of preservatives in local anesthesia. "They also made suggestions on how to collect data regarding dental anesthetic.
Tom Renz, Attorney
No response received
TrialSiteNews
No response received
Dr. Joseph Mercola, Osteopathic Physician, Founder and Owner of Mercola.com
No response received
ICAN (Informed Consent Action Network)
July 25, 2023 responded stating "We will forward this to our team and if we have further questions, we will be in touch with you. We are honored to hear your ideas and for you to reach out to us. It is this kind of collaboration that moves us forward."
Dr. Pablo Campra, PhD in Chemical Sciences at University of Almeria, Biological Science Graduate at University of Granada, Professor of the Agronomy Department at University of Almeria in Spain
February 5, 2024 sent an email to inquire about Raman Mass Spectroscopy testing and if you could find graphene particles with it.
February 6, 2024 responded stating "Just Raman will not detect graphene if it is present in dispersed nanoparticles, and must be observed analized one by one. You can check the technique here."
https://www.researchgate.net/publication/355979001_DETECTION_OF_GRAPHENE_IN_COVID19_VACCINES
Dr. Ricardo Delgado Martin
No response received
Strategic Response Partners
No response received
Colleen Fitzgerald, NDSU Research and Creative Activity
January 3, 2024 responded stating "We don't currently have a Raman-Mass Spectrometer in our instrument portfolio. After careful consideration of your project, we have determined that the scope of the nanotechnology and number of possible contaminants would be challenging for our instrumentation and staff to provide reliable results."
Dr. Peter McCullough, MD, MPH
No response received
Dr. Diana Wojtkowiak
No response received
Applied Consumer Services, Inc.
January 25, 2024 we provided a sample of anesthetic and inquired about what testing method would be most appropriate to determine the ingredients in the anesthetic, potentially deformulation.
May 9, 2024 responded stating "Unfortunately we do not have the capabilities for this analysis."
Dr. Phillip Buckhaults, Ph.D. University of South Carolina, Drug and Discovery and Biomedical Sciences (DDBS) Collect of Pharmacy
February 5, 2024 sent an email to inquire about testing for graphene. No response received.
John Kouvetakis, Arizona State University School of Molecular Sciences
February 6, 2024 sent an email to inquire about testing for graphene. No response received.
Stuart Lindsay, Arizona State University, Center Director and Professor Biodesign Center for Single Molecule Biophysics, Regents Professor School of Molecular Sciences, Regents Professor Department of Physics, University Professor Biosocial Complexity Initiative, University Professor ASU SFI Center, University Professor Center for Biological Physics, University Professor ASU-SFI Fellow
February 6, 2024 sent an email to inquire about testing for graphene using Raman Mass Spectroscopy
February 6, 2024 responded stating "I was very surprised to hear about the possibility of graphene in dental anesthetic. A very recent research paper (J. Molecular Liquids vol 366 p120301 2022) has explored the use of graphene to extend the release time of small molecule anesthetic in theoretical study. I am not aware of any experimental studies. Graphene does have distinct features in Raman spectrum, but I doubt you'd see them in any solution not made black by the presence of graphene. Given this timescale, I think it inconceivable that the FDA would have permitted this. The simple solution is to ask the manufacturer to state that graphene is NOT in the solution."
Nicholas Stephanopolos, Arizona State University, Associate Professor School of Molecular Sciences, Associate Professor Sustainable Macromolecular Materials and Manufacturing Associate Faculty, Associate Director and Assistant Professor Biodesign Center for Molecular Design and Biomimetics
February 6, 2024 sent an email to inquire about testing for graphene. No response received.
Rajkrishna Dutta, Princeton University Associate Research Scholar, Department of Geosciences
April 24, 2024 sent an email to inquire about testing for graphene using Raman Microspectroscopy
April 24, 2024 responded stating "I am following up on your email regarding performing some Raman measurements on your product and looking at traces of graphene. We are happy to try this if you can send us a sample."
April 24, 2024 sent an email to verify testing would be completed using Raman Microspectroscopy
April 24, 2024 responded stating "Yes, this will be micro-Raman. I was trying to read up on this and with micro-raman, it still may be challenging to distinguish the different forms of carbon, but it should be doable."
April 25, 2024 sent samples of anesthetic for testing
May 6, 2024 received confirmation that anesthetic samples were received for testing
June 4, 2024 sent an email to check on progress with testing
June 4, 2024 responded stating "Sorry about the delay. Yes, I did give this a shot, it is difficult to get good signal, but from what we could get, it did not look like we had graphene. I am out of town for a couple of weeks, but will get back to this once I return."
Maria Crisler BS, CLS(NCA), MBA/HCM, CEO Abeytu Naturals Product Line
June 25, 2024 sent samples of anesthetic to be tested using an Electron Microscope
Nanoimaging Services
July 17, 2024 sent samples of anesthetic for particle characterization
COMMUNICATION WITH MANUFACTURERS
Articaine Hydrochloride 4% with EPI 1:200,000
Manufacturer: Pierrel
Date: February 20, 2023
Is there any graphene, graphene hydroxide, graphene oxide, carbon nanoparticles, hydrogel or lipid nanoparticles added to your Articaine Hydrochloric 4% Local Anesthetic?
Date: February 23, 2023
Date: February 27, 2023
Date: October 12, 2023
Updated letter sent to Pierrel
Date: October 18, 2023
Date: April 10, 2024
Date: April 11, 2024
Date: April 15, 2024
Date: May 7, 2024
Date: May 8, 2024
Prilocaine Hydrochloride 4% with EPI 1:200,000
Manufacturer: DentsplySirona
Date: February 20, 2023
Is there any graphene, graphene hydroxide, graphene oxide, carbon nanoparticles, hydrogel or lipid nanoparticles added to your Citanest Plain dental anesthetic?
Date: April 10, 2023
DentsplySirona was contacted through our distribution representative asking the following questions:
1. Did you add anything to the injectable product that is not needed for its function?
2. Does the injectable product contain graphene?
3. Does the injectable product contain graphene oxide?
4. Does the injectable product contain graphene hydroxide?
5. Does the injectable product contain lipid nanoparticle technology? (the technology which can be used to deliver a payload to the cells of the body, not necessarily considered an ingredient)
6. Does the injectable product contain a hydrogel technology? (might not by considered an ingredient)
7. Does the injectable product contain a technology, payload or ingredient that is not needed for its function?
8. Does the manufacturer have a contract or agreement with a third party to include a technology, payload or ingredient that is not needed for the injectable product?
Date: September 28, 2023
As of the date this web page was published, we have received no response from DentsplySirona regarding our questions. We will update the page if we receive correspondence from them.
Date: October 12, 2023
Updated letter sent to DentsplySirona
Carbocaine 3%
Manufacturer: Septodont
Date: February 21, 2023
Is there any graphene, graphene hydroxide, graphene oxide, carbon nanoparticles, hydrogel or lipid nanoparticles added to your Carbocaine Local Anesthetic?
Date: September 28, 2023
As of the date this web page was published, we have received no response from Septodont regarding our questions. We will update the page if we receive correspondence from them.
Date: October 12, 2023
Updated letter sent to Septodont
Lidocaine HCI 2% with EPI 1:100,000
Manufacturer: Septodont
Date: February 20, 2023
Is there any graphene, graphene hydroxide, graphene oxide, carbon nanoparticles, hydrogel or lipid nanoparticles added to your Lidocaine 2% Local Anesthetic?
Date: October 12, 2023
Updated letter sent to Septodont
OnSet
Manufacturer: OnPharma
Date: March 28, 2023
OnPharma was contacted through our distribution representative asking the following questions:
1. Did you add anything to the injectable product that is not needed for its function?
2. Does the injectable product contain graphene?
3. Does the injectable product contain graphene oxide?
4. Does the injectable product contain graphene hydroxide?
5. Does the injectable product contain lipid nanoparticle technology? (the technology which can be used to deliver a payload to the cells of the body, not necessarily considered an ingredient)
6. Does the injectable product contain a hydrogel technology? (might not be considered an ingredient)
7. Does the injectable product contain a technology, payload or ingredient that is not needed for its function?
8. Does the manufacturer have a contract or agreement with a third party to include a technology, payload or ingredient that is not needed for the injectable product?
Date: April 4, 2023
LUNDSTROM FAMILY DENTISTRY TREATMENT CONSENT
